{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:58:32Z","timestamp":1794916712758,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00198-021-05822-9","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T19:53:34Z","timestamp":1612209214000},"page":"1053-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3139-0713","authenticated-orcid":false,"given":"H.","family":"Ejlsmark-Svensson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rolighed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Harsl\u00f8f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"key":"5822_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158. https:\/\/doi.org\/10.1016\/S0140-6736(09)60507-9","journal-title":"Lancet"},{"key":"5822_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaac.2013.12.025","volume":"53","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Cusano NE, Khan AA et al (2014) Primary hyperparathyroidism. Nat Rev Dis Prim 53:417\u2013424.e5. https:\/\/doi.org\/10.1016\/j.jaac.2013.12.025","journal-title":"Nat Rev Dis Prim"},{"key":"5822_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","volume":"154","author":"DM Press","year":"2013","unstructured":"Press DM, Siperstein AE, Berber E, Shin JJ, Metzger R, Jin J, Monteiro R, Mino J, Swagel W, Mitchell JC (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surg (United States) 154:1232\u20131238. https:\/\/doi.org\/10.1016\/j.surg.2013.06.051","journal-title":"Surg (United States)"},{"key":"5822_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","volume":"71","author":"N Yu","year":"2009","unstructured":"Yu N, Donnan PT, Murphy MJ, Leese GP (2009) Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf) 71:485\u2013493. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03520.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5822_CR5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PHG, Zhou HC, Nishimoto S, Amy Liu IL, Harari A, Haigh PI, Adams AL (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98:1122\u20131129. https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1001\/jamainternmed.2019.1747","volume":"179","author":"EA Alore","year":"2019","unstructured":"Alore EA, Suliburk JW, Ramsey DJ, Massarweh NN, Balentine CJ, Singh H, Awad SS, Makris KI (2019) Diagnosis and management of primary hyperparathyroidism across the Veterans Affairs health care system. JAMA Intern Med 179:1220\u20131227. https:\/\/doi.org\/10.1001\/jamainternmed.2019.1747","journal-title":"JAMA Intern Med"},{"key":"5822_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.surg.2020.04.066","volume":"169","author":"CD Seib","year":"2020","unstructured":"Seib CD, Meng T, Suh I, Cisco RM, Lin DT, Morris AM, Trickey AW, Kebebew E (2020) Undertreatment of primary hyperparathyroidism in a privately insured US population: decreasing utilization of parathyroidectomy despite expanding surgical guidelines. Surgery. 169:87\u201393. https:\/\/doi.org\/10.1016\/j.surg.2020.04.066","journal-title":"Surgery."},{"key":"5822_CR8","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"5822_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1001\/archinte.1987.00370110079012","volume":"147","author":"G Kochersberger","year":"1987","unstructured":"Kochersberger G, Buckley NJ, Leight GS, Martinez S, Studenski S, Vogler J, Lyles KW (1987) What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 147:1951\u20131953","journal-title":"Arch Intern Med"},{"key":"5822_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","volume":"109","author":"RJ Wilson","year":"1988","unstructured":"Wilson RJ (1988) Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109:959\u2013962. https:\/\/doi.org\/10.7326\/0003-4819-109-12-959","journal-title":"Ann Intern Med"},{"key":"5822_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/17453678909149275","volume":"60","author":"K Larsson","year":"1989","unstructured":"Larsson K, Lindh E, Lind L, Persson I, Ljunghall S (1989) Increased fracture risk in hypercalcemia: bone mineral content measured in hyperparathyroidism. Acta Orthop 60:268\u2013270. https:\/\/doi.org\/10.3109\/17453678909149275","journal-title":"Acta Orthop"},{"key":"5822_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0039-6060(05)80017-0","volume":"118","author":"AM Kenny","year":"1995","unstructured":"Kenny AM, MacGillivray DC, Pilbeam CC et al (1995) Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 118:109\u2013114","journal-title":"Surgery"},{"key":"5822_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/eje.1.02225","volume":"155","author":"S De Geronimo","year":"2006","unstructured":"De Geronimo S, Romagnoli E, Diacinti D et al (2006) The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol 155:415\u2013420. https:\/\/doi.org\/10.1530\/eje.1.02225","journal-title":"Eur J Endocrinol"},{"key":"5822_CR14","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"Vignali E, Viccica G, Diacinti D et al (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94:2306\u20132312. https:\/\/doi.org\/10.1210\/jc.2008-2006","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1530\/eje.1.01985","volume":"153","author":"H Kaji","year":"2005","unstructured":"Kaji H, Yamauchi M, Chihara K, Sugimoto T (2005) The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism. Eur J Endocrinol 153:373\u2013378. https:\/\/doi.org\/10.1530\/eje.1.01985","journal-title":"Eur J Endocrinol"},{"key":"5822_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-13-0305","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Verga U, Scillitani A, Beck-Peccoz P, Chiodini I (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169:155\u2013162. https:\/\/doi.org\/10.1530\/EJE-13-0305","journal-title":"Eur J Endocrinol"},{"key":"5822_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","volume":"234","author":"K Larsson","year":"1993","unstructured":"Larsson K, LJUNGHALL S, KRUSEMO UB et al (1993) The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med 234:585\u2013593. https:\/\/doi.org\/10.1111\/j.1365-2796.1993.tb01017.x","journal-title":"J Intern Med"},{"key":"5822_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla S, Melton LJ, Wermers RA et al (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700\u20131707. https:\/\/doi.org\/10.1359\/jbmr.1999.14.10.1700","journal-title":"J Bone Miner Res"},{"key":"5822_CR19","first-page":"4875","volume":"163","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Mollerup CL, Fr\u00f8kjaer VG et al (2000) Cohort study of fracture risk before and after surgery of primary hyperparathyroidism. BMJ Clin Res ed 163:4875\u20134878","journal-title":"BMJ Clin Res ed"},{"key":"5822_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","volume":"75","author":"N Yu","year":"2011","unstructured":"Yu N, Donnan PT, Leese GP (2011) A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 75:169\u2013176. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03958.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5822_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jocd.2012.11.013","volume":"16","author":"EM Lewiecki","year":"2013","unstructured":"Lewiecki EM, Miller PD (2013) Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk. J Clin Densitom 16:28\u201332. https:\/\/doi.org\/10.1016\/j.jocd.2012.11.013","journal-title":"J Clin Densitom"},{"key":"5822_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"SJ Silverberg","year":"1989","unstructured":"Silverberg SJ, Shane E, De La Cruz L et al (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283\u2013291","journal-title":"J Bone Miner Res"},{"key":"5822_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/jbmr.98","volume":"25","author":"S Hansen","year":"2010","unstructured":"Hansen S, Jensen JEB, Rasmussen L et al (2010) Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J Bone Miner Res 25:1941\u20131947. https:\/\/doi.org\/10.1002\/jbmr.98","journal-title":"J Bone Miner Res"},{"key":"5822_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00198-019-05186-1","volume":"31","author":"W Wang","year":"2020","unstructured":"Wang W, Nie M, Jiang Y, Li M, Meng X, Xing X, Wang O, Xia W (2020) Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism. Osteoporos Int 31:165\u2013173. https:\/\/doi.org\/10.1007\/s00198-019-05186-1","journal-title":"Osteoporos Int"},{"key":"5822_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1210\/jc.2017-01932","volume":"103","author":"NE Cusano","year":"2018","unstructured":"Cusano NE, Rubin MR, Silva BC, Tay YKD, Williams JM, Agarwal S, Omeragic B, Guo XE, Bilezikian JP (2018) Skeletal microstructure and estimated bone strength improve following parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 103:196\u2013205. https:\/\/doi.org\/10.1210\/jc.2017-01932","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR26","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen S, Hauge EM, Rasmussen L, Jensen JEB, Brixen K (2012) Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 27:1150\u20131158. https:\/\/doi.org\/10.1002\/jbmr.1540","journal-title":"J Bone Miner Res"},{"key":"5822_CR27","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1210\/jc.2012-4255","volume":"98","author":"BC Silva","year":"2013","unstructured":"Silva BC, Boutroy S, Zhang C, McMahon DJ, Zhou B, Wang J, Udesky J, Cremers S, Sarquis M, Guo XDE, Hans D, Bilezikian JP (2013) Trabecular bone score (TBS)-a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:1963\u20131970. https:\/\/doi.org\/10.1210\/jc.2012-4255","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR28","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99:3561\u20133569. https:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jc.2014-3441","volume":"100","author":"K Lundstam","year":"2015","unstructured":"Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Ros\u00e9n T, Nordenstr\u00f6m J, Jansson S, Hellstr\u00f6m M, Bollerslev J, SIPH Study Group (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100:1359\u20131367. https:\/\/doi.org\/10.1210\/jc.2014-3441","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR30","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/jbmr.3461","volume":"33","author":"H Ejlsmark-Svensson","year":"2018","unstructured":"Ejlsmark-Svensson H, Bislev LS, Lajlev S, Harsl\u00f8f T, Rolighed L, Sikjaer T, Rejnmark L (2018) Prevalence and risk of vertebral fractures in primary hyperparathyroidism: a nested case-control study. J Bone Miner Res 33:1657\u20131664. https:\/\/doi.org\/10.1002\/jbmr.3461","journal-title":"J Bone Miner Res"},{"key":"5822_CR31","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","volume":"103","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP (2018) Primary hyperparathyroidism. J Clin Endocrinol Metab 103:3993\u20134004","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR32","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415\u20135422. https:\/\/doi.org\/10.1210\/jc.2004-0028","journal-title":"J Clin Endocrinol Metab"},{"key":"5822_CR33","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114\u20133121. https:\/\/doi.org\/10.1210\/jc.2007-0219","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-05822-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:10:04Z","timestamp":1621267804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-05822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5822"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-05822-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}